RGLS Regulus: Bozor kapitallashuvining balans qiymatiga nisbati

Regulus Therapeutics, Inc. (RGLS) kompaniyasining rasmiy ramzlari

Regulus Therapeutics (RGLS) polkistoz buyrak kasalligiga qarshi kurashish uchun miRNA asosidagi dori vositalarini ishlab chiqadi hamda erkin pul oqimi (FCF) o'sishini ta'minlash uchun patent himoyasi va sherikliklardan foydalanadi. Bozor kapitalizatsiyasining buxgalteriya qiymatiga nisbati aktivlar baholash dinamikasini aks ettiradi, bunda 7.82 qiymati joriy darajani tavsiflaydi. Nukleotid sintezini avtomatlashtirish tadqiqotlarni optimallashtiradi, tashqi CROlarga qat'iy boshqaruv nazorati ostida testlarni autsorsing qilish esa operatsion xatarlarni kamaytiradi.

Regulus (RGLS): Kapitallashuvning balans qiymatiga nisbati 04.07.2022dan 05.07.2025gacha

RGLS (Regulus Therapeutics, Inc.): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- narx va narxlar bo'yicha konsensus prognoz:
Narx grafigi Regulus Therapeutics|RGLS - Tahlilchilar median maqsadi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Regulus Therapeutics Inc|RGLS - Biznes qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar Regulus Therapeutics|RGLS - Buxgalteriya kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati regulusrx.com|RGLS - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Regulus Therapeutics|RGLS - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning kapitalga nisbati Regulus Therapeutics Inc|RGLS - Kompaniyaning umumiy yig'indi qarzi|Balans kapitallashuviga qarzlar Regulus Therapeutics Inc
Kompaniyaning dastlabki tahlili:Regulus Therapeutics RGLS
Regulus Therapeutics, Inc. original mahsuloti

Regulus Therapeutics RNA asosidagi dori vositalarini ishlab chiqishda xarajatlarni minimallashtirish va testlarning yuqori daromadliligini saqlab qolish uchun samarali logistikadan foydalanadi. Ushbu operatsion muvaffaqiyatlar bozor qiymatining buxgalteriya qiymatiga nisbati ko'rsatkichida aks etgan. Ushbu ko'rsatkich aksiyaning joriy narxini sof aktivlarning buxgalteriya qiymati bilan solishtiradi. Narxning buxgalteriya qiymatiga nisbatini tahlil qilish biznesning haddan tashqari yuqori baholanganligini aniqlash imkonini beradi. Narxning buxgalteriya qiymatiga nisbati tendentsiyasi investitsiya riskining darajasidan signal beradi.

Asosiy raqobatchilar

Tempus Labs - Bozor qiymatining balans qiymatiga nisbati|qiagen.com (QGEN) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati Ionis (IONS)|Kapitallashuvning balans qiymatiga nisbati RGEN|Bozor qiymatining balans qiymatiga nisbati Avidity RNA|Kapitallashuvning balans qiymatiga nisbati CRISPR (CRSP)|Bozor kapitallashuvining balans qiymatiga nisbati WGS (GeneDx Holdings Corp.)|ultragenyx.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Beam Therapeutics (BEAM)|SRPT - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati TWST|10x (TXG) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Intellia Therapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining xususiy kapitalga nisbati stoketherapeutics.com (STOK)|Kapitallashuvning sof aktivlarga nisbati BLFS|Bozor kapitallashuvining balans qiymatiga nisbati WVE (Wave Life Sciences Ltd)|Bozor qiymatining balans qiymatiga nisbati Maze Tx MAZE|SION - Bozor qiymatining balans qiymatiga nisbati|Prime Medicine, Inc. - Kapitallashuvning sof aktivlarga nisbati|TSHA: Bozor kapitallashuvining balans qiymatiga nisbati|uniQure - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi MeiraGTx Holdings|RGNX - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Solid Corp (SLDB)|Kapitallashuvning sof aktivlarga nisbati Ocugen, Inc.|Bozor kapitallashuvining balans qiymatiga multiplikatori pacb.com (PACB)|Bozor kapitallashuvining balans qiymatiga nisbati Benitec Biopharma|Balans qiymatiga nisbatan bozor qiymati Design Therapeutics Inc DSGN|RCKT (Rocket Pharmaceuticals Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|FDMT: Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati lexeotx.com LXEO|Korro Bio (KRRO) - Balans qiymatiga nisbatan bozor qiymati|EDIT (Editas Medicine) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati SLN|PRQR - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi codexis.com (CDXS)|SGMO: Bozor kapitallashuvining balans qiymatiga nisbati|NAUT - Bozor qiymatining balans qiymatiga koeffitsiyenti|Metagenomi - Kapitallashuvning sof aktivlarga nisbati|precisionbiosciences.com (DTIL) - Bozor kapitallashuvining balans qiymatiga nisbati|GBIO - Kapitallashuvning sof aktivlarga nisbati|Boundless Bio Inc (BOLD) - Bozor kapitallashuvining balans qiymatiga multiplikatori|XCUR: Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Celsion Corporation|Bozor kapitallashuvining balans qiymatiga nisbati PHIO (Phio Pharmaceuticals)|Kapitallashuvning sof aktivlarga nisbati MBIO (mustangbio.com)|Bozor qiymatining balans qiymatiga nisbati RNAZ|Bionano Genomics Inc. - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Applied DNA Sciences (APDN)|BLUE - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati IPA (immunoprecise.com)|OMGA (Omega Therapeutics Inc) - Bozor qiymatining xususiy kapitalga nisbati|Bozor qiymatining balans qiymatiga nisbati Singular Genomics Systems Inc|Bozor qiymatining balans qiymatiga nisbati SYRS|TBIO (Telesis Bio, Inc.) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi traconpharma.com (TCON)|UBX - Bozor kapitallashuvining balans qiymatiga nisbati